Ternaria Biosciences Revenue
Biotechnology Research • 
Reykjavík, Capital Region, Iceland • 1-10 Employees
$
Ternaria Biosciences revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contact at Ternaria Biosciences
Steingrimur Stefansson
Chief Technology Officer Arterna
Company overview
| Headquarters | Reykjavík, Capital Region, Iceland |
| Websites | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
About Ternaria Biosciences
Ternaria Biosciences is a biotechnology company revolutionizing the way we understand and utilize RNA enzymes, for the production of high quality RNA. Ternaria is part of the rapidly expanding field of RNA applications in therapeutics, agriculture and beyond.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Entry
Employees by Department
Ternaria Biosciences has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Ternaria Biosciences has never raised funding before.
Spain
United Kingdom
United States
Frequently asked questions
Ternaria Biosciences is located in Reykjavík, Capital Region, IS.
Ternaria Biosciences generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.
Ternaria Biosciences has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Ternaria Biosciences was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.
Ternaria Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
